Human Genome Epidemiology Literature Finder
|
Records 1 - 3 (of 3 Records) |
| Query Trace: Astrocytoma and KRAS[original query] |
|---|
| Targetable signaling pathway mutations are associated with malignant phenotype in IDH-mutant gliomas. Clinical cancer research : an official journal of the American Association for Cancer Research 2014 Jun 20 (11): 2898-909. Wakimoto Hiroaki, Tanaka Shota, Curry William T, Loebel Franziska, Zhao Dan, Tateishi Kensuke, Chen Juxiang, Klofas Lindsay K, Lelic Nina, Kim James C, Dias-Santagata Dora, Ellisen Leif W, Borger Darrell R, Fendt Sarah-Maria, Vander Heiden Matthew G, Batchelor Tracy T, Iafrate A John, Cahill Daniel P, Chi Andrew |
| [Pilocytic astrocytoma with KRAS gene mutation: a clinicopathological analysis of two cases]. Zhonghua bing li xue za zhi = Chinese journal of pathology 2024 4 53 (5): 477-479. T P Yu, M X Zhang, J Y Zhang, J Gong, Q Zhou, N Ch |
| TERTp Mutation and its Prognostic Value in Glioma Patients Under the 2021 WHO Classification: A Real-World Study. Cancer medicine 2025 1 14 (2): e70533. Hao Xing, Delin Liu, Junlin Li, Yulu Ge, Xiaopeng Guo, Wenlin Chen, Dachun Zhao, Yixin Shi, Yilin Li, Yaning Wang, Yuekun Wang, Yu Xia, Jiaming Wu, Tingyu Liang, Hai Wang, Qianshu Liu, Shanmu Jin, Tian Qu, Siying Guo, Huanzhang Li, Tianrui Yang, Kun Zhang, Yu Wang, Wenbin |
- Page last reviewed:Feb 1, 2024
- Content source: